Clinical Trial

MBA Early Feasibility Study

Name: MBA Early Feasibility Study — clinical trial record (NCT07564375)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The MBA 25-04 study is a prospective, multicenter, non-randomized, single-arm, early feasibility study designed to assess the initial safety of the MBA device through five years following the index endovascular procedure.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-05-01.

Trial Details

NCT Number	NCT07564375
Lead Sponsor	W.L.Gore & Associates Collaborators: NAMSA
Conditions	Thoracic Aortic Aneurysm, Penetrating Aortic Ulcers (PAUs), Thoracic Aortic Dissection, Pseudoaneurysm
Enrollment	20 participants
Start Date	2026-09
Primary Completion	2029-11 (estimated)
Study Completion	2034-11 (estimated)
Updated on ClinicalTrials.gov	2026-06-01